Literature DB >> 559530

Neostriatal administration of somatostatin:differential effect of small and large doses on behavior and motor control.

M Rezek, V Havlicek, L Leybin, C Pinsky, E A Kroeger, K R Hughes, H Friesen.   

Abstract

The administration of small doses of somatostatin (SRIF) (0.01 and 0.1 microgram) into the neostriatal complex of unrestrained, freely moving rats induced general behavioral excitation associated with a variety of stereotyped movements, tremors, and a reduction of rapid eye movements (REM) and deep slow wave sleep (SWS). In contrast, the higher doses of SRIF (1.0 and 10.0 microgram) caused movements to be uncoordinated and frequently induced more severe difficulties in motor control such as contralateral hemiplegia-in-extension which restricted or completely prevented the expression of normal behavioral patterns. As a result, the animals appeared drowsy and inhibited. Analysis of the sleep-waking cycle revealed prolonged periods of a shallow SWS while REM sleep and deep SWS were markedly reduced; electroencephalogram recordings revealed periods of dissociation from behavior. The administration of endocrinologically inactive as well as the active analogues of SRIF failed to induce effects comparable with those observed after the administration of the same dose of the native hormone (10.0 microgram).

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 559530     DOI: 10.1139/y77-034

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  4 in total

1.  Relative expression of mRNA for the somatostatin receptors in the caudate putamen of C57BL/6J and 129P3/J mice: strain and heroin effects.

Authors:  Stefan D Schlussman; Jared Cassin; Orna Levran; Yong Zhang; Ann Ho; Mary Jeanne Kreek
Journal:  Brain Res       Date:  2010-05-15       Impact factor: 3.252

2.  Selective central activation of somatostatin receptor 2 increases food intake, grooming behavior and rectal temperature in rats.

Authors:  A Stengel; M Goebel; L Wang; J Rivier; P Kobelt; H Monnikes; Y Tache
Journal:  J Physiol Pharmacol       Date:  2010-08       Impact factor: 3.011

3.  Central injection of the stable somatostatin analog ODT8-SST induces a somatostatin2 receptor-mediated orexigenic effect: role of neuropeptide Y and opioid signaling pathways in rats.

Authors:  Andreas Stengel; Tamer Coskun; Miriam Goebel; Lixin Wang; Libbey Craft; Jorge Alsina-Fernandez; Jean Rivier; Yvette Taché
Journal:  Endocrinology       Date:  2010-07-07       Impact factor: 4.736

Review 4.  Central actions of somatostatin-28 and oligosomatostatin agonists to prevent components of the endocrine, autonomic and visceral responses to stress through interaction with different somatostatin receptor subtypes.

Authors:  Andreas Stengel; Jean Rivier; Yvette Taché
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.